Advertisement
Advertisement
GSK
GSK plc - ADR
50.87
USDSponsored
+0.62
+1.23%
Sep 01, 09:49 UTC -4
Open
GSK Earnings Reports
Positive Surprise Ratio
GSK beat 35 of 42 last estimates.
83%
Next Report
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$9.15B
/$0.52
Implied change from Q2 26 (Revenue/ EPS)
+8.76%
/+4.00%
Implied change from Q3 25 (Revenue/ EPS)
+7.01%
/-5.45%
GSK plc - ADR earnings per share and revenue
On Jul 28, 2026, GSK reported earnings of 0.50 USD per share (EPS) for Q2 26, beating the estimate of 0.47 USD, resulting in a 6.65% surprise. Revenue reached 8.41 billion, compared to an expected 8.49 billion, with a -0.91% difference. The market reacted with a +3.33% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of 0.52 USD, with revenue projected to reach 9.15 billion USD, implying an increase of 4.00% EPS, and increase of 8.76% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Immatics N.V. Ordinary Shares
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.43
Actual
-$0.46
Surprise
-5.70%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-Surprise
-
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-Actual
-$0.35
Surprise
-
Chemomab Therapeutics Ltd. - ADR
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.24
Surprise
-56.86%
EVOGENE LTD.
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.14
Surprise
+49.16%
FAQ
What were GSK plc - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, GSK plc - ADR reported EPS of $0.50, beating estimates by 6.65%, and revenue of $8.41B, -0.91% below expectations.
How did the market react to GSK plc - ADR's Q2 2026 earnings?
The stock price moved up 3.33%, changed from $51.98 before the earnings release to $53.71 the day after.
When is GSK plc - ADR expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for GSK plc - ADR's next earnings report?
Based on 5
analysts, GSK plc - ADR is expected to report EPS of $0.52 and revenue of $9.15B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement